Direkt zum Inhalt
Merck

In situ forming implants for periodontitis treatment with improved adhesive properties.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (2014-05-17)
M P Do, C Neut, E Delcourt, T Seixas Certo, J Siepmann, F Siepmann
ZUSAMMENFASSUNG

Novel in situ forming implants are presented showing a promising potential to overcome one of the major practical hurdles associated with local periodontitis treatment: limited adhesion to the surrounding tissue, resulting in accidental expulsion of at least parts of the implants from the patients' pockets. This leads to high uncertainties in the systems' residence times at the site of action and in the resulting drug exposure. In the present study, the addition of different types and amounts of plasticizers (acetyltributyl citrate and dibutyl sebacate) as well as of adhesive polymers (e.g., cellulose derivatives such as hydroxypropyl methylcellulose) is shown to allow for a significant increase in the stickiness of poly(lactic-co-glycolic acid)-based implants. The systems are formed in situ from N-methyl pyrrolidone-based liquid formulations. Importantly, at the same time, good plastic deformability of the implants can be provided and desired drug release patterns can be fine-tuned using several formulation tools. The antimicrobial activity of this new type of in situ forming implants, loaded with doxycycline hyclate, was demonstrated using the agar well diffusion method and multiple Streptococcus strains isolated from the oral microflora of patients suffering from periodontitis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
1-Methyl-2-pyrrolidon, ACS reagent, ≥99.0%
Sigma-Aldrich
1-Methyl-2-pyrrolidon, ReagentPlus®, 99%
Sigma-Aldrich
Doxycyclin -hyclat
Sigma-Aldrich
1-Methyl-2-pyrrolidon, suitable for HPLC, ≥99%
Sigma-Aldrich
Natriummetabisulfit, ReagentPlus®, ≥99%
Sigma-Aldrich
1-Methyl-2-pyrrolidon, biotech. grade, ≥99.7%
Sigma-Aldrich
Natriummetabisulfit, reagent grade, 97%
Sigma-Aldrich
Natriummetabisulfit, puriss., meets analytical specification of Ph. Eur., BP, NF, FCC, E223, dry, 97-100.5%
Sigma-Aldrich
Dibutylsebacat, ≥97.0% (GC)
Sigma-Aldrich
DL-Cystein, technical grade
USP
Doxycyclin -hyclat, United States Pharmacopeia (USP) Reference Standard
Supelco
Natriummetabisulfit, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Natriummetabisulfit, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dibutylsebacat, technical grade
Supelco
Doxycyclin -hyclat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Natriummetabisulfit, analytical standard
Supelco
1-Methyl-2-pyrrolidon, analytical standard
Supelco
Doxycyclin -hyclat, VETRANAL®, analytical standard
Sigma-Aldrich
Natriummetabisulfit, tested according to Ph. Eur.
Doxycyclin -hyclat, European Pharmacopoeia (EP) Reference Standard
Supelco
Dibutylsebacat, Pharmaceutical Secondary Standard; Certified Reference Material